Acceleron Pharma Inc. Debt to Equity Ratio 2013-2021 | XLRN
Current and historical debt to equity ratio values for Acceleron Pharma Inc. (XLRN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Acceleron Pharma Inc. debt/equity for the three months ending September 30, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-09-30 | $0.07B | $0.72B | 0.10 |
| 2021-06-30 | $0.07B | $0.76B | 0.10 |
| 2021-03-31 | $0.07B | $0.81B | 0.08 |
| 2020-12-31 | $0.08B | $0.86B | 0.09 |
| 2020-09-30 | $0.05B | $0.90B | 0.06 |
| 2020-06-30 | $0.06B | $0.42B | 0.14 |
| 2020-03-31 | $0.05B | $0.41B | 0.12 |
| 2019-12-31 | $0.06B | $0.45B | 0.12 |
| 2019-09-30 | $0.06B | $0.47B | 0.12 |
| 2019-06-30 | $0.05B | $0.50B | 0.10 |
| 2019-03-31 | $0.05B | $0.51B | 0.10 |
| 2018-12-31 | $0.02B | $0.29B | 0.08 |
| 2018-09-30 | $0.02B | $0.32B | 0.06 |
| 2018-06-30 | $0.02B | $0.33B | 0.06 |
| 2018-03-31 | $0.02B | $0.35B | 0.05 |
| 2017-12-31 | $0.02B | $0.37B | 0.07 |
| 2017-09-30 | $0.02B | $0.36B | 0.06 |
| 2017-06-30 | $0.02B | $0.19B | 0.11 |
| 2017-03-31 | $0.02B | $0.21B | 0.10 |
| 2016-12-31 | $0.02B | $0.23B | 0.10 |
| 2016-09-30 | $0.03B | $0.23B | 0.15 |
| 2016-06-30 | $0.03B | $0.24B | 0.13 |
| 2016-03-31 | $0.03B | $0.26B | 0.11 |
| 2015-12-31 | $0.04B | $0.11B | 0.34 |
| 2015-09-30 | $0.03B | $0.13B | 0.20 |
| 2015-06-30 | $0.03B | $0.14B | 0.20 |
| 2015-03-31 | $0.03B | $0.15B | 0.20 |
| 2014-12-31 | $0.03B | $0.16B | 0.19 |
| 2014-09-30 | $0.03B | $0.17B | 0.20 |
| 2014-06-30 | $0.05B | $0.17B | 0.26 |
| 2014-03-31 | $0.04B | $0.18B | 0.24 |
| 2013-12-31 | $0.07B | $0.06B | 1.14 |
| 2013-09-30 | $0.05B | $0.08B | 0.71 |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
| 2012-09-30 | $0.00B | 0.00 | |
